Surgical evacuation

PROCEDURE2 trials

Sponsors

Balt USA, Microvention-Terumo, Inc.

Conditions

Chronic Subdural HematomasSubdural Hematoma, Chronic

Unknown Phase

The SQUID Trial for the Embolization of the Middle Meningeal Artery for Treatment of Chronic Subdural Hematoma (STEM)

CompletedNCT04410146

Balt USASubdural Hematoma, Chronic

Start: 2020-11-01End: 2024-05-23Updated: 2026-06-04

PHIL™ Middle Meningeal Artery Embolization for First-Line Treatment of Chronic Subdural Hematoma IDE Trial

Not yet recruitingNCT07576998

Microvention-Terumo, Inc.Chronic Subdural Hematomas

Start: 2026-12-31End: 2031-05-31Target: 475Updated: 2026-05-08

Related Papers

Embolization of the Middle Meningeal Artery for Chronic Subdural Hematoma

New England Journal of Medicine2024-11-20152 citations

Managing non-acute subdural hematoma using liquid materials: a Chinese randomized trial of middle meningeal artery treatment (MAGIC-MT)-protocol.

2023-09-1413 citations